tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Opus Genetics Announces Positive Phase 3 Trial Results
PremiumCompany AnnouncementsOpus Genetics Announces Positive Phase 3 Trial Results
1M ago
Opus Genetics’ Phentolamine Ophthalmic Solution meets primary Phase 3 endpoint
Premium
The Fly
Opus Genetics’ Phentolamine Ophthalmic Solution meets primary Phase 3 endpoint
1M ago
Opus Genetics Secures $2M Funding for Gene Therapy
Premium
Company Announcements
Opus Genetics Secures $2M Funding for Gene Therapy
1M ago
Opus Genetics says LYNX-2 trial met primary endpoint
PremiumThe FlyOpus Genetics says LYNX-2 trial met primary endpoint
2M ago
Opus Genetics’ Promising Gene Therapy Advances and Strategic Partnerships Reinforce Buy Rating
Premium
Ratings
Opus Genetics’ Promising Gene Therapy Advances and Strategic Partnerships Reinforce Buy Rating
2M ago
Opus Genetics reports Q1 EPS (24c) vs (29c) last year
Premium
The Fly
Opus Genetics reports Q1 EPS (24c) vs (29c) last year
2M ago
Opus Genetics initiated with a Buy at Craig-Hallum
PremiumThe FlyOpus Genetics initiated with a Buy at Craig-Hallum
4M ago
Opus Genetics announces data from patient in Phase 1/2 trial of OPGx-LCA5
Premium
The Fly
Opus Genetics announces data from patient in Phase 1/2 trial of OPGx-LCA5
4M ago
Opus Genetics urges stockholders to vote for company’s nine board nominees
Premium
The Fly
Opus Genetics urges stockholders to vote for company’s nine board nominees
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100